Skip to main content

Table 1 Comparison of the general conditions between the two groups \( \left[\overline{x}\kern0.5em \pm \kern0.5em \mathrm{s}/\mathrm{case}\ \left(\%\right)\right] \)

From: Effect of lipid metabolism disorder on liver function in patients with malignant tumors after chemotherapy: a case-control study

Item

Observation (n = 265)

Control (n = 163)

P

Age

62.0 ± 9.3

61.3 ± 9.0

0.247

Male

123 (46.4)

76 (46.6)

0.996

BMI

22.2 ± 2.0

21.8 ± 2.6

0.086

Tumor types

Gastrointestinal cancer

105 (39.6)

61 (37.4)

0.650

Lung cancer

47 (17.7)

37 (22.7)

0.209

Breast cancer

56 (21.1)

32 (19.6)

0.709

Gynecologic cancer

25 (9.4)

16 (9.8)

0.896

Malignant lymphoma

10 (3.8)

6 (3.7)

0.961

Other tumors

22 (8.3)

11 (6.7)

0.559

Surgery

182 (68.7)

116 (71.2)

0.587

ALT before chemotherapy

26.2 ± 7.8

25.4 ± 9.4

0.361

TC before chemotherapy

5.5 ± 1.2

4.7 ± 0.7

0.000

TG before chemotherapy

1.8 ± 0.6

1.3 ± 0.2

0.000

HDL before chemotherapy

1.3 ± 0.5

1.4 ± 0.4

0.000

LDL before chemotherapy

3.2 ± 1.1

2.9 ± 0.8

0.010

  1. BMI body mass index, ALT alanine aminotransferase, TC total cholesterol, TG triglycerides, HDL high-density lipid, LDL low-density lipoprotein; P < 0.05 was considered statistically significant